Once-daily aminoglycosides in the treatment of gram-positive endocarditis

Annals of Pharmacotherapy

Volumn 33, Issue 5, 1999, Pages 600-606

  Tam, Vincent H ^a   Preston, Sandra L ^b   Briceland, Laurie L ^a  

^a ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b Albany College of Pharmacy ^*

Author keywords

Aminoglycosides; Endocarditis; Once daily dosing

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFTRIAXONE; GENTAMICIN; NAFCILLIN; NETILMICIN; OXACILLIN; PENICILLIN G; PLACEBO; PROCAINE PENICILLIN; TOBRAMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL INFECTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENTIATION; ENDOCARDITIS; GRAM POSITIVE BACTERIUM; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; MULTICENTER STUDY; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AMINOGLYCOSIDES; ANIMALS; CLINICAL TRIALS; DATA COLLECTION; DRUG ADMINISTRATION SCHEDULE; ENDOCARDITIS, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS;

EID: 0033053811     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18316     Document Type: Article

References (43)

1. Bansal RC. Infective endocarditis. Med Clin North Am 1995;79:1205-40.
2. Healy DP, Wong-Beringer A. Endocarditis. In: Young LY, Koda-Kimble MA, eds. Applied therapeutics: the clinical use of drugs. 6th ed. Vancouver, WA: Applied Therapeutics, Inc., 1995:57.1-23.
3. Scheld WM, Sande MA. Endocarditis and intravascular infections. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1995:740-83.
4. Littler WA. Infective endocarditis. Med Int 1992:4356-60.
5. Francioli P, Etienne J, Hoigné R, Thys JP, Gerber A. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone sodium for 4 weeks: efficacy and outpatient treatment feasibility. JAMA 1992;267: 264-7.
6. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms. JAMA 1995;274:1706-13.
7. Chambers HF, Sande MA. Antimicrobial agents: the aminoglycosides. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: Mcgraw-Hill, 1995: 1103-21.
8. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991;35:399-405.
9. De Broe ME, Verbist L, Verpooten GA. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man. J Antimicrob Chemother 1991;27(suppl C):41-7.
10. Verpooten GA, Giuliano RA, Verbist L, Eestermans G, De Broe ME. Once-daily dosing decreases renal accumulation of gentamicin and netilmicin. Clin Pharmacol Ther 1989;45:22-7.
11. Laurent G, Carlier MB, Rollman B, Van Hoof F, Tulkens P. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol 1982; 31:3861-70.
12. De Broe ME, Paulus GJ, Verpooten GA, Roels F, Buyssens N, Wedeen R, et al. Early effects of gentamicin, tobramycin, and amikacin on the human kidney. Kidney Int 1984;25:643-52.
13. Tran Ba Huy P, Bernard P, Schacht J. Kinetics of gentamicin uptake and release in the rat: comparison of inner ear tissues and fluids with other organs. J Clin Invest 1986;77:1492-500.
14. Bates RD, Nahata MC. Once-daily administration of aminoglycosides. Ann Pharmacother 1994;28:757-66.
15. Nordström L, Lerner SA. Single daily dose therapy with aminoglycosides. J Hosp Infect 1991;18(suppl A):117-29.
16. Rotschafer JC, Rybak MJ. Single daily dosing of aminoglycosides: a commentary. Ann Pharmacother 1994;28:797-801.
17. Hustinx WNM, Hoepelman IM. Aminoglycoside dosage regimens. Is once a day enough? Clin Pharmacokinet 1993;25:427-32.
18. Preston SL, Briceland LL. Single daily dosing of aminoglycosides. Pharmacotherapy 1995;15:297-316.
19. Barclay ML, Begg EJ, Hickling KG. What is the evidence for once-daily aminoglycoside therapy? Clin Pharmacokinet 1994;27:32-48.
20. Ferriols-Lisart R, Alós-Almiñana M. Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Am J Health-Syst Pharm 1996;53: 1141-50.
21. Galløe AM, Graudal N, Christensen HR, Kampmann JP. Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety. Eur J Clin Pharmacol 1995;48:39-43.
22. Barza M, Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a meta-analysis. BMJ 1996;312:338-45.
23. Moore RD, Lietman PS, Smith CR. Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. J Infect Dis 1987;155:93-9.
24. Zhanel GG, Craig WA. Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides. Clin Pharmacokinet 1994;27:377-92.
25. Bayer AS, Crowell D, Nast CC, Norman DC, Borrelli RL. Intravegetation antimicrobial distribution in aortic endocarditis analyzed by computer-generated model: implication for treatment. Chest 1990;97:611-7.
26. Maire P, Barbaut X, Vergnaud JM, El Brouzi M, Confesson MA, Pivot C, et al. Computation of drug concentrations in endocardial vegetations in patients during antibiotic therapy. Int J Bio-Med Comput 1994;36:77-85.
27. Xiong YQ, Caillon J, Kergueris MF, Drugeon H, Baron D, Potel G, et al. Adaptive resistance of Pseudomonas aeruginosa induced by aminoglycosides and killing kinetics in a rabbit endocarditis model. Antimicrob Agents Chemother 1997;41:823-6.
28. Carbon C. Experimental endocarditis: a review of its relevance to human endocarditis. J Antimicrob Chemother 1993;31(suppl D):71-85.
29. Fantin B, Carbon C. Importance of the aminoglycoside dosing regimen in the penicillm-netilmicin combination for treatment of Enterococcus faecalis-induced experimental endocarditis. Antimicrob Agents Chemother 1990;34:2387-91.
30. Gavalda J, Cardona PJ, Almirante B, Capdevila JA, Laguarda M, Pou L, et al. Treatment of experimental endocarditis due to Enterococcus faecalis using once-daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob Agents Chemother 1996; 40:173-8.
31. Gavalda J, Pahissa A, Almirante B, Laguarda M, Crespo E, Pou L, et al. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob Agents Chemother 1995;39:2098-103.
32. Blatter M, Fluckiger U, Entenza J, Glauser MP, Francioli P. Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis. Antimicrob Agents Chemother 1993;37:1971-6.
33. Saleh-Mghir A, Cremieux AC, Vallois JM, Muffat-Joly M, Devine C, Carbon C. Optimal aminoglycoside dosing regimen for penicillin-to-bramycin synergism in experimental Streptococcus adjacens endocarditis. Antimicrob Agents Chemother 1992;36:2403-7.
34. Fantin B, Pangon B, Potel G, Vallois JM, Caron F, Bure A, et al. Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis. Antimicrob Agents Chemother 1989;33:767-70.
35. Bugnon D, Potel G, Xiong YQ, Caillon J, Kergueris MF, Le Conte P, et al. In vivo antibacterial effects of simulated human serum profiles of once-daily versus thrice-daily dosing of amikacin in a Serratia marcescens endocarditis experimental model. Antimicrob Agents Chemother 1996;40:1164-9.
36. Hessen MT, Pitsakis PG, Levison ME. Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo. Antimicrob Agents Chemother 1989;33:608-11.
37. Schwank S, Blaser J. Once-versus thrice-daily netilmicin combined with amoxicillin, penicillin, or vancomycin against Enterococcus faecalis in a pharmacodynamic in vitro model. Antimicrob Agents Chemother 1996; 40:2258-61.
38. Francioli P, Rush W, Stamboulian D. Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study. Clin Infect Dis 1995;21:1406-10.
39. Sexton DJ, Tenenbaum MJ, Wilson WR, Steckelberg JM, Tice AD, Gilbert D, et al. Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Clin Infect Dis 1998;27:1470-4.
40. Prins JM, Koopmans RP, Büller HR, Kuijper EJ, Speelman P. Easier monitoring of aminoglycoside therapy with once-daily dosing schedules. Eur J Clin Microbiol Infect Dis 1995;14:531-5.
41. Blaser J, König C, Simmen HP, Thurnheer U. Monitoring serum concentrations for once-daily netilmicin dosing regimens. J Antimicrob Chemother 1994;33:341-8.
42. Nicolau DP, Freeman CD, Belliveau PP, Nightingale CH, Ross JW, Quintiliani R. Experience with a once-daily aminoglycoside program administered to 2184 adult patients. Antimicrob Agents Chemother 1995; 39:650-5.
43. MacGowan AP, Reeves DS. Serum monitoring and practicalities of once-daily aminoglycoside dosing (letter). J Antimicrob Chemother 1994; 33:349-50.